MetLife, Inc. (NYSE:MET)‘s stock had its “neutral” rating reissued by equities researchers at Credit Suisse Group in a research note issued on Monday. They presently have a $53.00 price objective on the financial services provider’s stock, down from their prior price objective of $64.00. Credit Suisse Group’s price objective would suggest a potential upside of 10.44% from the company’s previous close.

Several other analysts have also weighed in on the stock. TheStreet lowered shares of MetLife from a “b-” rating to a “c” rating in a research note on Tuesday, May 16th. ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. set a $51.00 price objective on shares of MetLife and gave the company a “sell” rating in a research note on Friday, July 7th. BidaskClub upgraded shares of MetLife from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 10th. Finally, Wells Fargo & Company reiterated a “buy” rating on shares of MetLife in a research note on Thursday, May 4th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $59.31.

MetLife (NYSE MET) opened at 47.99 on Monday. The company has a 50-day moving average of $48.46 and a 200-day moving average of $47.25. MetLife has a 1-year low of $37.17 and a 1-year high of $52.07. The firm has a market cap of $51.01 billion, a price-to-earnings ratio of 564.59 and a beta of 1.46.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $17.39 billion during the quarter, compared to analyst estimates of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. MetLife’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.83 EPS. Analysts predict that MetLife will post $4.83 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Credit Suisse Group Reaffirms “Neutral” Rating for MetLife, Inc. (MET)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/28/credit-suisse-group-reaffirms-neutral-rating-for-metlife-inc-met.html.

Several hedge funds have recently bought and sold shares of the company. BlackRock Inc. raised its stake in MetLife by 2.2% in the second quarter. BlackRock Inc. now owns 69,957,359 shares of the financial services provider’s stock valued at $3,843,457,000 after buying an additional 1,481,489 shares during the last quarter. Vanguard Group Inc. raised its stake in MetLife by 2.1% in the second quarter. Vanguard Group Inc. now owns 66,723,143 shares of the financial services provider’s stock valued at $3,665,769,000 after buying an additional 1,358,523 shares during the last quarter. State Street Corp raised its stake in MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock valued at $2,589,297,000 after buying an additional 680,903 shares during the last quarter. Franklin Resources Inc. raised its stake in MetLife by 1.6% in the second quarter. Franklin Resources Inc. now owns 25,704,204 shares of the financial services provider’s stock valued at $1,412,189,000 after buying an additional 414,032 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock valued at $541,427,000 after buying an additional 664,918 shares during the last quarter. Hedge funds and other institutional investors own 74.23% of the company’s stock.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.